chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lost my taste; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 59-year-old female patient received bnt162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "hepatis C", start date: 2011 (unspecified if ongoing), notes: hepatis C back in 2011 (History). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, The first shot I took I lost my taste), for Covid-19 immunization, reaction(s): "I lost my taste". The following information was reported: AGEUSIA (non-serious), outcome "unknown", described as "lost my taste". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The first shot she took she lost her taste, and she could smell stuff strong and when she got tested for COVID she did not have COVID. Then when she took the second shot the same thing happened and again, she did not have COVID, but it was just something that she told the nurse that gave the shot, and she says she was never done like that before. So, she thought of share, reported because the all of that in actual time for anything different but she said you could not be you got to have corona. You must have COVID if you do smell and she said no, she don't have it and she was tested, and she did not have that (further not clarified).  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
pt exp localized redness, swelling, ``hot cramps & spasms in all limbs even the amputated limb- leg. inject site red & swollen, arm swollen from shoulder to elbow, had spasms on 5/12 still sore & warm but getting better but still sore.
p/vax pt had fast heartbeat then dizziness, sweating & fever broke out;temp not taken rt leg stiff;c/o sleepiness;stills feels woozy & off balance;
mild fever some irritability; death;reporter states this is a poss adverse event w/a time assoc to vax;cannot determine cause (vaccine?/effect (death);pt low nl birth weight; sleep position abdomen
sl diff swallowing;BP 122/84, R16, P88;epi given 514PM;520PM P96, R18, BP 110/70;525PM 911 called hives on chest;530PM BP 130/74, P95, R20, no wheezing;still scratchy throat;
Vaccine was not diluted and dispensed. No signs or symptoms of adverse outcome after 1 hours.
Pt experienced erythematous area of induration developed adjacent to injection site measuring 3 x 8 cm. No evidence of infection.
This spontaneous report was received from a registered nurse referring to a female patient of unknown age. The patient's medical history, concurrent conditions, drug and allergy history were not reported.    On 27-MAY-2017, the patient was vaccinated with an expired ZOSTAVAX lot # L032184 and expiration date on 27-MAY-2017 (route and dose were not provided) for prophylaxis. The patient's concomitant therapy was not reported. In addition, it was reported that before vaccination, the patient transported the expired vaccine from an unspecified pharmacy to her office and that was exposed to unknown temperatures for an unknown period of time during transport. No adverse symptoms reported. Additional information has been requested.
Nausea, headache, diarrhea.  Symptoms less day after. Laid in bed with lots of rest and water
sore arm; achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and PAIN (achy) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 001C21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu vaccine. Past adverse reactions to the above products included No adverse event with Flu vaccine.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PAIN (achy). On 21-May-2021, PAIN IN EXTREMITY (sore arm) and PAIN (achy) had resolved. No concomitant medications were reported No treatment medications were reported   This case was linked to MOD-2021-436416, MOD-2021-436438 (Patient Link).
Pfizer Dose 1 2/22/2021 (EN6200) Pfizer Dose 2 3/17/2021 (EN6205) COVID Positive 7/21/2021  7/19/21: Presented to ED with GI issues and discharged.  7/21/21: The patient presents with fatigue and 93 y/o patient, he, presents to the emergency department with complaint of weakness that began 4-5 days ago. Pt.'s wife accompanied the patient to the emergency department and provided some history. Pt.'s wife states that the patient had a fever 2 days ago and has intermittent coughs. The patient states that weakness is not a recurring problem for him. Pt. PHx includes Barrett's esophagus, HTN, and GERD. This is a 93-year-old male with history of coronary artery disease, hypertension, hyperlipidemia and type 2 diabetes mellitus who presented to the emergency department with confusion and cough. Patient reports that he has been coughing for the past few days.  Wife reports that he had a temperature of 100° F on Sunday.  He woke up this morning around 3:00 a.m. confused and disoriented.  He was also feeling very weak.  His symptoms are improving.  He denies chest pain, dizziness, blurry vision, palpitations, abdominal pain, nausea, vomiting or diarrhea.  Patient was fully vaccinated for COVID-19. In the emergency department, patient was found to have a temperature of 99.6°.  Labs showed a creatinine of 1.56, lactic acid of 2.2, WBC count of 3.8 and platelets of 87. CT head without contrast showed no acute findings. Chest x-ray showed developed an bibasilar pneumonia. Patient received a dose of IV Rocephin, azithromycin and IV fluids.  7/30/21: Pt discharged with P.o.  Zinc sulfate and vitamin-C,  P.o. Decadron course,  Albuterol HFA,  COVID-19 precautions per CDC guidelines, hemodynamically stable for discharge. Will discharge to skilled nursing facility. Patient agrees with plan of care. Follow-up with PCP in 3-5 days
Pt received her 11 yr vaccines. Tdap, HPV in her (L) deltoid - Per Mom had swelling from injection site down to her fingers. Advice Elevate, Ice and Benadryl. No further complaints or swelling
Information has been received from a health professional concerning a 5 year old female who in November 2007, was vaccinated with Gardasil.  Per the reporter, the patient was inadvertently vaccinated in the arm, unknown which arm, with Gardasil.  Subsequently, the patient experienced incorrect vaccine administered and inappropriate age.  The patient sought unspecified medical attention in the physician's office.  No other information was available.  Additional information has been requested.
CHIEF COMPLAINT:   Sore throat , tonsils swollen. diff swallowing onset 2 days ago getting worse. Voice is hoarse/muffled. Fever , fatigue Nausea. COVID + on Saturday, Onset of covid symptoms Sat as well. Ibuprofen/tylenol @ home Last dose yesterday   HISTORY OF PRESENT ILLNESS:     19-year-old male past no significant past medical history presents for COVID-19 and sore throat.  Reports that he did have his Covid vaccinations but did not have the booster shot.  On Saturday, 6 days ago, diagnosed with COVID-19.  Now having tonsillitis, difficulty swallowing, muffled voice.  Associated with fever, fatigue, nausea.  Taking ibuprofen and Tylenol at home, no other modifying factors reported.  Symptoms are moderate in severity intensity and acute in duration for the past week.  No drooling reported.
approx 2PM began crying uncontrolled; pt had different cry & parent was unable to calm pt; had recvd Ibuprofen;  slept from 430PM till 8AM;
Patient presented to the pharmacy with a DOB of 8/1/2003, which would have made him 18 the day of administration, to receive his COVID-19 vaccine. After vaccination we were able to determine via his insurance plan that the patient had falsified his DOB to receive a the vaccine.
At 3:48 patient began to feel light headed, had hot flashes, and blurry vision. No injuries occurred at time of adverse event.
This spontaneous report as received from a Registered Nurse refers to multiple unspecified patients of unknown age and gender. The concurrent conditions and medical history of the patients were not reported. On unknown dates,  the patients were vaccinated with an improperly stored dose of MMR II with lot number M029230 and expiration date of 08-JUN-2018 (strength, dose and route of administration were not reported) for prophylaxis. The vaccine was stored from 47 Fahrenheit degrees (°F) to 77°F for 18 minutes and reconstituted with properly stored sterile diluent with lot number reported as N007550 and expiration date of 03-MAY-2018. There was no previous temperature excursion. The temperature excursions were detected by a data logger. No adverse effects were reported. This is one of several cases received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA009159: US-009507513-1705USA010583:
I got my shot on 2/12/21, I woke up on 2/13/21 and I had severe pain on my left arm, it was difficult to lift and move my arm because it is very weak. It is also very painful to touch.  Friends kept telling me the pain is going to go away, this is how the vaccination feels but it never went away, so I waited to go to the doctor. I can not remember when I went to Urgent Care, but the doctor told me the pain would go away, but it never did.  I still have pain, its not as sever as it was, but I still have pain to this day. I am still very limited with what I can do on my left side.
At approximately 8:00PM 3/16/2023 client started feeling achy then @ 10:00PM started shaking and couldn't stop this went on until about 1:00AM She took Tylenol and had no other symptoms.
Vaccine unavailable to order via weekly survey; No adverse event; Patient received a Moderna COVID19 vaccine bivalent as a second dose; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received a Moderna COVID19 vaccine bivalent as a second dose), PRODUCT AVAILABILITY ISSUE (Vaccine unavailable to order via weekly survey) and NO ADVERSE EVENT (No adverse event) in a 2-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215k22a) for COVID-19 prophylaxis.     No known drug allergy. It was unknown whether the patient ever been diagnosed with/ tested positive for COVID-19.     On 09-Feb-2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .2 milliliter. On 09-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (Patient received a Moderna COVID19 vaccine bivalent as a second dose). On an unknown date, the patient experienced PRODUCT AVAILABILITY ISSUE (Vaccine unavailable to order via weekly survey) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received a Moderna COVID19 vaccine bivalent as a second dose), PRODUCT AVAILABILITY ISSUE (Vaccine unavailable to order via weekly survey) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (Patient received a Moderna COVID19 vaccine bivalent as a second dose) and PRODUCT AVAILABILITY ISSUE (Vaccine unavailable to order via weekly survey).    Concomitant products were not provided. Patient received first dose was Moderna COVID19 vaccine monovalent 0.25 ml on 09Dec2022 at 13:05 Pm with lot AS1412B on left thigh. They advised was to redose the child immediately with Moderna monovalent since the bivalent booster dose is a suboptimal dose. Patient unable to receive the second dose within our practice, due to the vaccine expiration on 11Feb2023 and vaccine unavailable to order via weekly survey.  Treatment medication were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Feb-2023: Significant follow-up received contains Reporter address, Dosage information, Event and  narrative part updated.
itching under the skin near site of injection; swollen arm; This case was reported by a consumer via call center representative and described the occurrence of itchy skin in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included breast cancer and chronic sinusitis.   On 17th February 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 18th February 2020, 1 days after receiving Shingrix, the patient experienced itchy skin and swelling arm. On 21st February 2020, the outcome of the itchy skin was recovered/resolved. On an unknown date, the outcome of the swelling arm was recovered/resolved.   It was unknown if the reporter considered the itchy skin and swelling arm to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix and experienced a swollen arm and itching under the skin near site of injection, lasting 4 days before resolution. The reporter consented to follow up. For tolerances of 2nd dose refer case US2020135560.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020135560:same reporter.
A non-serious report was received from a consumer of feeling sick concerning a 38-year-old male.  No medical history or concomitant medications were reported for this patient.  The patient initiated FLUMIST on an unreported date.  The patient felt sick following FLUMIST vaccine administration.  No further information was provided. Outcome for the adverse event was not reported.  The reporter did not provide a causality assessment for the adverse event reported.  The reporting source of this case is spontaneous, thus the sponsor's comment is not applicable.
This spontaneous report as received from a registered nurse referring to 63 year old male patient. There was no pertinent medical history, drug reactions or concomitant medications reported. On 02-OCT-2015 the unspecified male patient was vaccinated with an expired dose of ZOSTAVAX (lot # K007987; expired date reported as 23-SEP-2015) (dose and route were not reported). No adverse effects reported. It was unspecified if the patient sought any medical attention. Additional information has been requested.
Patient reports she received the vaccine 10:30am on 5/14 and had some injection site soreness. By 10pm on 5/15, there was a warm, raised, red area 5-6 inches below the injection site on her left arm. Patient reports it does not hurt and denies any difficulty breathing, etc.
I felt lousy but I didn't have a fever at the time. I had a cough and it was mostly feeling lousy with no energy. I didn't feel like doing anything. I don't know if they were typical symptoms, but it was 4 to 5 days of not feeling well. My wife and I felt lethargic and tired most of the time, but we did not suffer. It was just a mild case. I did go to the urgent care and tested positive for COVID-19. I was prescribed PAXLOVID. After about 5-6 days, I felt pretty good. Then a couple of days later, I started getting a cough again. I went to the doctor again and I tested negative for COVID-19. I still had a cough and they diagnosed it as bronchitis. I was given a 10 day prescription of amoxicillin. I was also given an injection at the hip of ceftriaxone. The doctor mentioned at that time that I could have also had long COVID-19 because of the persistent cough that can last for some time. I do still cough on occasion but it's gotten better, and I've had more energy recently. I feel like I'm getting over it.
I?ve been having Occipital Nerve pain up head and behind ears, also Cervical spine nerve pain in my neck shoulders, ears, behind ears, arms and hands since October 11, 2021. Had CT of occipital nerve & CT of  Cervical spine. I?ve taken Gapapentin & Percocet, but couldn?t tolerate the meds. On take Tylenol now for intermittent relief. I don?t sleep because of the pain. The pain is worse on the opposite side of my head & ears that I may manage to fall asleep on, Ice packs & heat gives minor relief. I?m still waiting on a consul with a pain management for possible nerve block injection. The neurologist referred me to pain management because I?m on blood thinners.
developed pityriasis rosea patch a couple of week after getting the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0182) via an unspecified route of administration in the left arm on 08May2021 at 14:00(at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient medical history was reported as none. Patient had no known allergies to food, medications or other products. Concomitant medication was not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8735) via an unspecified route of administration in the left arm on 17Apr2021 at 14:00(at the age of 19-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24May2021, the patient experienced a pityriasis rosea patch a couple of weeks after getting the vaccine. There was no other changed in lifestyle nor any new medication. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event developed pityriasis rosea patch was recovering, at the time of this report.
Fatigue, fever, arm pain at injection site,  muscle & joint pain,  loss of taste & smell, diarrhea, severe low blood pressure.  Fainted 2x, and wacky heart rhythms.
Three days after the second dose of the vaccine I started coughing, wheezing and having shortness of breath on exertion. This symptoms did'nt alarm me at first since I have this asthma  for couple years. Then after a  week from receiving my second dose vaccine in 02/28/21, my symptoms got worst. In additon to having SOB, wheezing , coughing I developed generalized hives. I started taking steroids started 03/13/21 to ease my symptoms. Today I started feeling better and able to walk for 30 minutes without any problems. Hives also subsided. I had no asthma or hives attack for the last three years.
tongue feels a bit swollen; This is a spontaneous report from a contactable consumer (patient). A 92-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number: EL3249 and expiration date unknown) via an unspecified route of administration on 27Jan2021 (at 92 years old) at a SINGLE DOSE for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications were unspecified; patient is taking a lot of medications. The patient stated that she just had the vaccine on Wednesday, 27Jan2021 and her tongue feels a bit swollen on an unspecified date in Jan2021. But it was getting better now. Patient asked what she should take as it seems to lighten a little bit. Since then it was quite bad, it is still swollen but not as bad as it was. Outcome of the event was recovering.
loopy; difficult sleeping; achy feeling in both legs and buttocks; ruptured blood vessel in left eye; arm inflamed; arm hot; Arm red; arm itchy; mild headache; queasy GI symptoms; achy pain at injection site; A spontaneous report was received from a consumer concerning a 72-years-old  elder female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events achy pain at injection site, mild headache, queasy gi symptoms, arm itchy, arm inflamed, arm red, arm hot, achy feeling in both legs and buttocks, loopy, difficult sleeping, ruptured blood vessel in left eye.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 18 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 023M20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 18 Feb 2021, the patient experienced the event(s) achy pain at injection site,On 19 Feb 2021, the patient experienced the event(s) mild headache, queasy gi symptoms. On 28 Feb 2021, the patient experienced the event(s) arm itchy, arm inflamed, arm red, arm hot. On an unknown date, the patient experienced the event(s) achy feeling in both legs and buttocks, loopy, difficult sleeping. On 3 Mar 2021, the patient experienced the events ruptured blood vessel in left eye which was considered as seriousness criteria.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of event(s), achy pain at injection site, mild headache, queasy gi symptoms, arm itchy, arm inflamed, arm red, arm hot, achy feeling in both legs and buttocks, loopy, difficult sleeping, ruptured blood vessel in left eye was UNKNOWN.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Noted bruising at site (dime-size) on 11/1/07 3 inch area of redness noted on 11/3/07. "Patient" denies swelling or pain at site.
Fri Dec 2: Chills; body aches; oral pain in molars left side of mouth; dry, cracked, itchy, swollen lips Sun, Dec 4:  vomiting, diarrhea  Lip pain and swelling is persisting and medical treatment will be sought today
Pneumonia began with high fever that would come down a little with Tylenol then go back up.  Turned into deep cough, lack of breathing properly without oxygen assistance.  Lethargy.
Patient started having fevers within 3 hours of receiving the vaccination. Even with 3 mg MOTRIN and TYLENOL intermittently he was still having fever highest of which was measured the next morning at 104. She was told to bring him to the ER for evaluation. They concurred adverse reaction to to vaccine and to continue MOTRIN and TYLENOL fevers continued for 4 days after and no weight bearing for 2 days after immunization.
Narrative: 69yo male patient with- PROBLEM LAST MOD PROVIDER Neurocognitive disorder 11/08/2021(ICD-IO-CM R41.9) Alcohol dependence (ICD-10-CM 09/21/2021 FI0.20) Alcohol abuse (ICD-10-CM F10.10) 08/16/2021 Depression (ICD-10-CM F32.9) 08/16/2021 Allergic rhinitis (ICD-10-CM 11/22/2019 J30.9) Microscopic hematuria ICD-10-CM 11/22/2019 R31.29) GERD - Gastro-esophageal reflux disease 11/22/2019 (ICD-10-CM V0I.9) Obstructive sleep apnea syndrome 11/28/2017 (ICD-10-CM G47.33) Bilateral hearing loss (ICD-10-CM 01/06/2017 H90.O) Benign hypertension (ICD-10-CM 01/06/2017 R 110.) Hyperlipidemia (ICD-10-CM E78.2) 01/06/2017  Coronary arteriosclerosis 01/06/2017 (ICD-10-CM 125.10) Pt received covid vaccine (J&J) on 3/10/2021. Committed suicide on 12/17/2021. Death is not related to covid vaccine.
MA gave DTap+IPV+ hib , then gave seperate IPV(IPOL) vaccine.  So pt. got 2 doses of IPV  and wasn't due for Hib vaccine